David Calhoun
Overview
Explore the profile of David Calhoun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
709
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Booth 3rd J, Allen N, Calhoun D, Carson A, Deng L, Goff Jr D, et al.
Am J Prev Med
. 2019 Feb;
56(3):368-375.
PMID: 30777156
Introduction: Earlier development of cardiovascular disease risk factors in blacks versus whites may result from differences in maintaining health behaviors. Age-specific racial differences in maintaining health behaviors from ages 18...
12.
Navarro-Soriano C, Martinez-Garcia M, Torres G, Barbe F, Caballero-Eraso C, Lloberes P, et al.
J Hypertens
. 2019 Jan;
37(6):1269-1275.
PMID: 30676482
Rationale: Continuous positive airway pressure (CPAP) can significantly reduce blood pressure (BP) levels in patients with resistant hypertension and sleep apnea (OSA); however, the effect on patients with refractory hypertension...
13.
Thomas S, Booth 3rd J, Dai C, Li X, Allen N, Calhoun D, et al.
J Am Heart Assoc
. 2018 Jul;
7(14).
PMID: 29997132
Background: Blacks have higher blood pressure levels compared with whites beginning in childhood. Few data are available on racial differences in the incidence of hypertension from young adulthood through middle...
14.
Parikh V, Thaler E, Kato M, Gillespie M, Nguyen S, Withrow K, et al.
Heart Rhythm
. 2018 Apr;
15(8):1165-1170.
PMID: 29678782
Background: Implantable hypoglossal nerve upper airway stimulation (HNS) is a novel strategy approved by the US Food and Drug Administration for the management of moderate-to-severe obstructive sleep apnea (OSA) in...
15.
Flack J, Calhoun D, Schiffrin E
Am J Hypertens
. 2017 Dec;
31(2):133-135.
PMID: 29228096
No abstract available.
16.
Thomas S, Booth 3rd J, Bromfield S, Seals S, Spruill T, Ogedegbe G, et al.
J Am Soc Hypertens
. 2017 Mar;
11(4):204-212.e5.
PMID: 28285829
Blood pressure (BP) can differ substantially when measured in the clinic versus outside of the clinic setting. Few population-based studies with ambulatory blood pressure monitoring (ABPM) include African Americans. We...
17.
Thomas S, Calhoun D
J Am Soc Hypertens
. 2017 Jan;
11(2):122-129.
PMID: 28109722
Blood pressure (BP) varies over 24 hours. During normal sleep, BP typically decreases by 10% or more. Research suggests that disordered sleep, particularly sleep deprivation and obstructive sleep apnea, is...
18.
Bhatt H, Ghazi L, Calhoun D, Oparil S
Curr Cardiol Rep
. 2016 Aug;
18(10):98.
PMID: 27566331
Systolic blood pressure (SBP) is an important predictor of cardiovascular disease (CVD) outcomes. Lowering SBP has been shown to reduce CVD morbidity and mortality, but the optimal SBP target continues...
19.
Bhatt H, Siddiqui M, Judd E, Oparil S, Calhoun D
J Am Soc Hypertens
. 2016 May;
10(6):493-9.
PMID: 27129931
The prevalence of pseudoresistant hypertension (HTN) due to inaccurate BP measurement remains unknown. Triage BP measurements and measurements obtained at the same clinic visit by trained physicians were compared in...
20.
Biederman R, Young A, Doyle M, Devereux R, Kortright E, Perry G, et al.
J Biomed Sci Eng
. 2016 Mar;
8(3):213-225.
PMID: 27011783
Background: Increased relative wall thickness in hypertensive left ventricular hypertrophy (LVH) has been shown by echocardiography to allow preserved shortening at the endocardium despite depressed LV midwall circumferential shortening (MWCS)....